Abstract

Endothelial dysfunction is a key player in both the onset and development of atherosclerosis. No study has examined whether healthy dietary patterns can improve microvascular endothelial function in patients with coronary heart disease (CHD) in the long-term and whether this relationship can affect patient’s risk of CHD recurrence. In the CORDIOPREV study, a randomized, double-blind, controlled trial, dietary intervention with either the Mediterranean diet or a low-fat diet was implemented in 1,002 CHD patients. A laser-doppler flowmetry was performed at baseline and after 6 years of follow up in 664 patients, evaluating the effects of this dietary intervention on microvascular basal flow and reactive hyperaemia area, as well as on the risk of CHD recurrence, based on the TRS2P risk score. Basal flow (97.78 ± 2.79 vs. 179.31 ± 5.06 arbitrary perfusion units, 83.38% increase, p < 0.001) and reactive hyperaemia area (4233.3 ± 127.73 vs. 9695.9 ± 205.23 arbitrary perfusion units per time, 129.04% increase, p < 0.001) improved after the dietary intervention in the cohort, without finding differences due to the diet (p > 0.05 for the diet-effect). When patients were stratified to low, moderate or high-risk of recurrence, basal flow was similarly increased in all three groups. However, reactive hyperaemia area was improved to a greater extent in patients at the low-risk group compared with those at moderate or high-risk. No differences were observed between diets. Healthy dietary patterns can improve microvascular endothelial function and this improvement persists in the long-term. Patients with a low-risk of CHD recurrence show a greater improvement in reactive vasodilation to ischemia than patients in the moderate or high-risk groups.

Highlights

  • From the initial 1,002 coronary heart disease (CHD) patients included in the CORDIOPREV study, a total of 664 patients were included in the study (See flow-chart included in the Supplemental Materials)

  • Dietary intervention with either Mediterranean diet (MedDiet) or low-fat diet (LFD) improved both basal flow (BF) (97.78 ± 2.79 arbitrary perfusion units (APU) vs. 179.31 ± 5.06 APU, 83.38% increase, p < 0.001) and reactive hyperaemia area (RHA) (4233.3 ± 127.73 arbitrary perfusion units per time (APUT) vs. 9695.9 ± 205.23 APUT, 129.04% increase, p < 0.001)

  • There were no differences in BF and RHA between risk groups and according to the dietary pattern (BF: 97.7 ± 6.3 vs. 87.7 ± 5.3 APU for MedDiet vs. LFD in the low-risk group; 100.4 ± 7.2 vs. 103.5 ± 6.1 APU for MedDiet vs. LFD in the moderate-risk group; 101.5 ± 8.1 vs. 98.9 ± 8.5 APU for MedDiet vs. LFD in the highrisk group, p > 0.05 all comparisons; RHA: 4251.96 ± 262.3 vs.4564.88 ± 300.3 APUT for MedDiet vs. LFD in the low-risk group; 4263.6 ± 256.7 vs. 3988.83 ± 306.7 APUT for MedDiet vs. LFD in the moderate-risk group; 3984.5 ± 389.5 vs. 4192.8 ± 470.8 APUT for MedDiet vs. LFD in the high-risk group, p > 0.05 all comparisons)

Read more

Summary

Objectives

The aim of the CORDIOPREV study was to examine the efficacy of a MedDiet rich in olive oil, compared with a LFD, to prevent new, major cardiovascular clinical events. CongesƟve Heart failure Hypertension Age ≥ 75

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call